Clinical Trial Update: A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics study of favipiravir in patients with severe influenza has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Influenza Human

Drugs mentioned

• Favipiravir (favipiravir)

Snippet

Sponsor: Capital Medical University | Conditions: Influenza, Human, Critical Illness | Phase 2 | Status: COMPLETED